Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2014
12/04/2014US20140356441 Core-shell type particles and method for producing the same
12/04/2014US20140356439 Lipidated glycoprotein particles and methods of use
12/04/2014US20140356420 Micro-particle comprising a protein extract from sweet potato for extending satiety and controlling blood glucose and lipid levels
12/04/2014US20140356418 Compositions for binding to amyloid proteins
12/04/2014US20140356383 Administration of an anti-gcc antibody-drug conjugate and a dna damaging agent in the treatment of cancer
12/04/2014US20140356380 Neutralizing Antibodies And Methods Of Use Thereof
12/04/2014US20140356378 BMP-1 Procollagen C-Proteinase for Diagnosis and Treatment of Bone and Soft Tissue Defects and Disorders
12/04/2014US20140356377 Compounds for use in boosting coagulation
12/04/2014US20140356361 Repeated administration of non-immunosuppressive antigen specific immunotherapeutics
12/04/2014US20140356345 New Proteases Able to Hydrolyze Gluten Peptides and Proteins at Acidic PH, from the Actinomycete Actinoallomurus
12/04/2014US20140356343 Composition for treating parkinson's disease
12/04/2014US20140356323 Compositions and Methods for Soft Tissue Augmentation
12/04/2014US20140356322 Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin Ligase
12/04/2014US20140356320 Polyoma virus jc peptides and proteins in vaccination and diagnostic applications
12/04/2014US20140356319 Compounds and pharmaceutical combinations for the treatment of neurodegenerative and ischemic brain diseases
12/04/2014US20140356318 Adoptive cell therapy with specific regulatory lymphocytes
12/04/2014US20140356287 PLOD2 as a Target of Intervention for Sarcoma Metastasis
12/04/2014US20140356286 Polypeptides Targeting Vascular Endothelial Growth Factor Receptor-2 and Alpha V Beta 3 Integrin
12/02/2014US8901277 Interferon alpha mutant and its polyethylene glycol derivative
12/02/2014US8901276 Peptide reagents and methods for detection of colon dysplasia
12/02/2014US8901167 Product and process for inhibition of biofilm development
12/02/2014US8901157 Compositions and methods of use of ritonavir for treating HCV
12/02/2014US8901103 Use of lipid conjugates in the treatment of diseases
12/02/2014US8901100 Tumor-specific delivery of therapeutic agents via liposomase
12/02/2014US8901084 Self-assembling peptide incorporating modifications and methods of use thereof
12/02/2014US8901083 Administration of angiocidin for the treatment of leukemia
12/02/2014US8901082 Immunity-inducing agent and method for detection of cancer
12/02/2014US8901081 Uses of GRS proteins or fragments thereof
12/02/2014US8901080 Conjugate of hyaluronic acid for cosmetic treatment and preparation method
12/02/2014US8901079 Treatment of parkinson's disease via administration of GLI-1 protein
12/02/2014US8901078 Crosslinked human or animal tissue products and their methods of manufacture and use
12/02/2014US8901076 Binding proteins inhibiting the VEGF-A receptor interaction
12/02/2014US8901075 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
12/02/2014US8901074 Methods of treating autoimmune diseases of the central nervous system (CNS) and neurodegenerative diseases
12/02/2014US8901073 Compounds and their effects on feeding behaviour
12/02/2014US8901072 Glycopeptide and lipoglycopeptide antibiotics with improved solubility
12/02/2014US8901071 Compounds and their use
12/02/2014US8901070 Pharmaceutical compositions comprising pore-forming proaerolysin protein (PRX302)
12/02/2014US8900880 Viral citrullinated peptides and uses thereof
12/02/2014US8900868 Hydrogel-based vascular lineage cell growth media and uses thereof
12/02/2014US8900823 Binding partners for the thyrotropin receptor and uses thereof
12/02/2014US8900636 Controlled release compositions
12/02/2014US8900633 Method for producing a product having a polymer matrix, implants made thereof and use thereof
12/02/2014US8900600 Identification, optimization and use of cryptic HLA-A24 epitopes for immunotherapy
12/02/2014US8900593 Glucagon/GLP-1 receptor co-agonists
12/02/2014US8900591 Vaccines comprising mutant GPCRs with increased conformational stability relative to parent receptors
12/02/2014US8900583 Methods for treatment of brain injury utilizing biologics
12/02/2014US8900576 Pharmaceutical compositions containing hyaluronic acid and collagenase for the topical treatment of wounds, burns and ulcers
12/02/2014US8900575 Compositions and methods for oxalate reduction
12/02/2014US8900574 Mesenchymal stem cells for the treatment of CNS diseases
12/02/2014US8900571 Compositions and soft tissue replacement methods
12/02/2014US8900567 Treatment of cone cell degeneration with transfected lineage negative hematopoietic stem cells
12/02/2014US8900564 Vaccine composition comprising an antigen and a peptide having adjuvant properties
12/02/2014US8900559 Composition and periodical delivery system for cellular rejuvenation
12/02/2014US8900555 Insulin derivative formulations for pulmonary delivery
12/02/2014US8900552 Treatment of glycogen storage disease type II
12/02/2014US8900551 Peptide which passes through blood-brain barrier and targets apoptosis of neurodegenerative brain disease site and uses thereof
11/2014
11/27/2014US20140351960 Artery- and vein-specific proteins and uses therefor
11/27/2014US20140350453 Bonding tissues and cross-linking proteins with naphthalimide compounds
11/27/2014US20140350218 Alpha-conotoxin peptides
11/27/2014US20140350083 Genetic Inhibition by Double-Stranded RNA
11/27/2014US20140350066 Compositions and their uses for gene therapy of bone conditions
11/27/2014US20140350047 Isoform-selective inhibitors and activators of pde3 cyclic nucleotide phosphodiesterases
11/27/2014US20140349949 Hyaluronic acid containing compositions for treatment of wounds, scars, post-surgical adhesion formation
11/27/2014US20140349948 Treatment of Chronic Constipation
11/27/2014US20140349946 Peptides derived from human bplp protein, polynucleotides coding for said peptides and antibodies directed against said peptides
11/27/2014US20140349944 Chaperone-based integrin inhibitors for the treatment of cancer and inflammatory diseases
11/27/2014US20140349943 Topical formulations of chemerin c15 peptides for the treatment of dermatological conditions
11/27/2014US20140349942 Methods for reducing oxidative damage
11/27/2014US20140349940 Prevention and reduction of blood loss
11/27/2014US20140349939 Methods for treating pain associated with chronic pancreatitis
11/27/2014US20140349937 Methods for treating benign prostatic hypertrophy (bph)
11/27/2014US20140349936 Compositions and methods for treating precocious puberty
11/27/2014US20140349935 Methods for treating metastatic stage prostate cancer
11/27/2014US20140349934 Method for inducing twin calving
11/27/2014US20140349933 Self-assembled composite ultrasmall peptide-polymer hydrogels
11/27/2014US20140349932 Angiogenically effective unit dose of fgf-2 and method of use
11/27/2014US20140349931 Detection and treatment of breast cancer
11/27/2014US20140349930 Treatment using neublastin polypeptides
11/27/2014US20140349928 Peptide pharmaceuticals for insulin resistance
11/27/2014US20140349926 Formulations for the treatment of diabetes
11/27/2014US20140349925 Novel insulin derivatives
11/27/2014US20140349924 Stable Non-Aqueous Pharmaceutical Compositions
11/27/2014US20140349923 Compositions And Methods For Treating Diabetes And/Or Obesity
11/27/2014US20140349922 Long-acting glp-1/glucagon receptor agonists
11/27/2014US20140349921 Hcv ns3 protease inhibitors
11/27/2014US20140349918 Derivatives of xanthone compounds
11/27/2014US20140349855 T cell receptor display
11/27/2014US20140348942 Treatments for Gastrointestinal Disorders
11/27/2014US20140348904 Exosomes With Transferrin Peptides
11/27/2014US20140348903 Robust controlled-release formulations
11/27/2014US20140348902 Tcl1 peptides for immunotherapy
11/27/2014US20140348901 Combinatorial methods and compositions for treatment of melanoma
11/27/2014US20140348899 Method and composition for treating cystitis
11/27/2014US20140348889 Compositions and Methods for Treating and Preventing Neointimal Stenosis
11/27/2014US20140348881 Method for diagnosing and treating dysautonomia and other dysautonomic conditions
11/27/2014US20140348879 Enteric soft capsules
11/27/2014US20140348859 Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
11/27/2014US20140348850 Method for reducing blood pressure using inhibitors of plasma kallikrein
11/27/2014US20140348849 Compounds and Method for Modulating Inflammatory Reactions
1 ... 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 ... 3163